Úsek pro vědu a výzkum

Professional Publications

Author
Title
Year of publication

Publications (3663)

[801]

Košťál, M.; Schwarz, J.; Ovesná, P.; et al.

Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: results from a registry of patients treated with Anagrelide

[year of publication 2020, impact factor 2.300 ]

[802]

Vydra, J.; Válková, V.; Čemusová, B.; Kolář, M.; Nováková, L.; Soukup, P.; Šálek, C.; Vraná, M.; Pytlík, R.; Lesný, P.; Vítek, A.; Cetkovský, P.; Marková, M.

Hematopoietic stem cell transplantation from haploidentical donors in aplasia after cladribine/cytarabine chemotherapy for refractory acute myeloid leukemia or myelodysplastic syndrome

[year of publication 2019, impact factor 2.298 ]

[803]

Lorkova, L.; Pospisilova, J.; Lacheta, J.; Leahomschi, S.; Zivny, J.; Cibula, D.; Zivny, J.; Petrak, J.

Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics.

[year of publication 2011, impact factor 2.297 ]

[804]

Machova Polakova, K.; Koblihova, J.; Stopka, T.

Role of epigenetics in chronic myeloid leukemia

[year of publication 2013, impact factor 2.286 ]

[805]

Marinov, I.; Kohoutová, M.; Tkáčová, V.; Lysák, D.; Holubová, M.; Stehlíková, O.; Železníková, T.; Žontar, D.; Illingworth, A.

Intra- and interlaboratory variability of paroxysmal nocturnal hemoglobinuria testing by flow cytometry following the 2012 practical guidelines for high-sensitivity paroxysmal nocturnal hemoglobinuria testing

[year of publication 2013, impact factor 2.283 ]

[806]

Grebeňová, D.; Halada, P.; Stulík, J.; Havlíček, V.; Hrkal, Z.

Protein changes in HL60 leukemia cells associated with 5-aminolevulinic acid-based photodynamic therapy : early effects on endoplasmic reticulum chaperones

[year of publication 2006, impact factor 2.278]

[807]

Chrenkova, V.; Hubka, V.; Cetkovsky, P.; Kouba, M.; Weinbergerova, B.; Lyskova, P.; Hornofova, L.; Hubacek, P.

Proven invasive pulmonary aspergillosis in stem cell transplant recipient due to aspergillus sublatus, a cryptic species of A. nidulans

[year of publication 2017, impact factor 2.278 ]

[808]

Dickinson, A.M.; Hromadníková, I.; Sviland, L.; Jackson, G.H.; Taylor, P.R.A.; Vavřinec, J.; Sedláček, P.; Čermáková, M.; Starý, J.; Vítek, A.; Sajdová, J.; Proctor, S.J.

Use of skin explant model for predicting GVHD in HLA-matched bone marrow transplants : effect of GVHD prophylaxis

[year of publication 2006, impact factor 2.277]

[809]

Moravcová, J.; Muchová, S.; Lukášová, M.; Klamová, H.; Březinová, J.; Gašová, Z.

Late molecular relapse in two CML patients in molecular remission after donor lymphocyte transfusion for post-BMT relapse

[year of publication 2006, impact factor 2.277]

[810]

Smetana, K.; Chan, P.K.; Jirásková, I.; Bush, H.

Nucleolar coefficient and cytochemistry of human blood monocytes

[year of publication 2006, impact factor 2.275]

[811]

Grebeňová, D.; Kuželová, K.; Smetana, K.; Pluskalová, M.; Cajthamlová, H.; Marinov, I.; Fuchs, O.; Souček, J.; Jarolím, P.; Hrkal, Z.

Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells

[year of publication 2006, impact factor 2.275]

[812]

Merkerová, M.; Dostál, J.; Hradilek, M.; Pichová, I.; Hrušková-Heidingsfeldová, O.

Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis

[year of publication 2007, impact factor 2.274]

[813]

Hrabovsky, S.; Folber, F.; Horacek, J.M.; Stehlikova, O.; Jelinkova, H.; Salek, C.; Doubek, M.

Comparison of real-time quantitative polymerase chain reaction and eight-color flow cytometry in assessment of minimal residual disease in adult acute lymphoblastic leukemia

[year of publication 2018, impact factor 2.274 ]

[814]

Vydra, J.; Šálek, C.; Schwarz, J.; Žák, P.; Novák, J.; Petečuková, V.; Pecherková, P.; Mayer, J.; Cetkovský, P.; Ráčil, Z.

Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission

[year of publication 2017, impact factor 2.274 ]

[815]

Provaznikova, D.; Geierova, V.; Kumstyrova; Kotlin, R.; Mikulenkova, D.; Zurkova, K.; Matoska, V.; Hrachovinova, I.; Rittich, S.

Clinical manifestation and molecular genetic characterization of MYH9 disorders

[year of publication 2009, impact factor 2.272]

[816]

Provaznikova, D.; Kumstyrova, T.; Kotlin, R.; Salaj, P.; Matoska, V.; Hrachovinova, I.; Rittich, S.

High-resolution melting analysis for detection of MYH9 mutations

[year of publication 2008, impact factor 2.271]

[817]

Holada, K.; Dyr, J.E.; Koubek, K.; Suttnar, J.; Simak, J.

Characterization of platelet antigen for CD-45RA monoclonal antibodies

[year of publication 2006, impact factor 2.270]

[818]

Santachiara Benerecetti, A.S.; Semino, O.; Passarino, G.; Torroni, A.; Brdicka, R.; Fellous, M.; Modiano, G.

The common, Near-Eastern origin of Ashkenazi and Sephardi Jews supported by Y-chromosome similarity

[year of publication 2006, impact factor 2.269]

[819]

Humlová, Z.; Klamová, H.; Janatková, I.; Malíčková, K.; Králíková, P.; Šterzl, I.; Roth, Z.; Hamšíková, E.; Vonka, V.

Changes of immunological profiles in patients with chronic myeloid leukemia in the course of treatment

[year of publication 2011, impact factor 2.263 ]

[820]

Pospisilova, D.; Cmejlova, J.; Ludikova, B.; Stary, J.; Cerna, Z.; Hak, J.; Timr, P.; Petrtylova, K.; Blatny, J.; Vokurka, S.; Cmejla, R.

The Czech National Diamond-Blackfan Anemia Registry: clinical data and ribosomal protein mutations update

[year of publication 2012, impact factor 2.259 ]